Instead, prophylactic intravenous lansoprazole (30 mg) was administered to protect the gastric mucosa, alongside oral palonosetron hydrochloride for antiemesis and granulocyte colony-stimulating factor (G-CSF) to prevent leukopenia and neutropenia. Here, CSF3 is linked to neutropenia.